Palisade Bio Inc (PALI)

[traderbbc1]

Well...Were getting closer to the finish line. It looks like we have significant positive results. I'm surprised we didn't see a double this AM.

[sharky]

GM all, plenty of room to move




$PALI

[GreenBio]

Hey guys, I’m at $13.61 - back from March.

Any light or news that’ll be bringing it back up to those levels?

[sharky]

GM all, chart trending north. :)




$PALI

[JackAskSlap]

Looking good here sharky..

[$treet $inatra]

nice volume, touched briefly $4.00

[$treet $inatra]

tighter range, rising volume, after lunch she pops!?

[$treet $inatra]

closing above $3.76 is key on the daily chart! nice volume early on compared to previous days

[sharky]

GM, looking good



$PALI

[$treet $inatra]

GM $PALI players! Huge Bids premarket!! NEWS must be coming out soon.. $4.00 breakout today!?

[sharky]

Plenty of room 6.00+ IMO




$PALI

[$treet $inatra]

$PALI wants to retest the $4.50 level and when news comes this micro-float runs quick and could pull a $NURO type run!!!

[sharky]

Just needs volume, saving powder to buy along with them, when she comes. :)



$PALI

[$treet $inatra]

$PALI global revenues growing https://www.benzinga.com/pressreleases/21/07/g21953640/palisade-bio-enters-into-worldwide-in-licensing-agreement-with-university-of-california-for-techno

Palisade Bio Enters into Worldwide In-Licensing Agreement with University of California for Technology to Support Target Identification, Drug Discovery, and Clinical Development

CARLSBAD, Calif., July 13, 2021 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) a late-stage biopharma company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced that it entered into an exclusive license with the Regents of the University of California, expanding its proprietary technology for detecting enzymatic protease activity in human clinical samples. Under the terms of this agreement, in combination with a related 2020 license from UC, the Company receives a worldwide exclusive license to patent rights covering certain engineered substrates and their use in measuring degradative enzymes for disease conditions, including cancer. This technology was originally developed in the laboratory of Dr. Michael Heller at University of California San Diego.

"Many chronic endocrine and inflammatory diseases are associated with chronic proteolytic enzyme leak from the GI tract. We have a deep understanding of the protease biology of the GI tract, and with the license we are expanding our proprietary whole-blood assay to identify the specific protease activity contributing to these diseases. As we expand our pipeline of drug products, these assets form a platform for novel target and drug discovery, as well as highly efficient patient selection and measurement of clinical response during drug development," said Tom Hallam, Ph.D., CEO of Palisade Bio.

[$treet $inatra]

good morning, once the short squeeze starts it'll be a sweet ride back above $10

[sharky]

GM all



$PALI

[$treet $inatra]

gap up today! lets get above $4.50 ~

[$treet $inatra]

easy double or triple as a swing trade!

[sharky]

PALI 50dma at 4.01, was trading over 10.00 in April





$PALI

[$treet $inatra]

Big bounce coming, news cycle is great ~

[$treet $inatra]

$4.40 highs premarket!!! MMs want that 30% + spike $UP $$$$

[sharky]

PALI news: Palisade Bio inks worldwide in-licensing agreement with University of California
Jul. 13, 2021 8:41 AM ETPalisade Bio, Inc. (PALI)By: Aakash Babu, SA News Editor
Palisade Bio (NASDAQ:PALI) has entered into an exclusive license with the Regents of the University of California, expanding its proprietary technology for detecting enzymatic protease activity in human clinical samples.
Under the terms of the agreement, the company receives a worldwide exclusive license to patent rights covering certain engineered substrates and their use in measuring degradative enzymes for disease conditions, including cancer.


Micro float here

$PALI

[sharky]

Nice news, was trading over 10.00 in April, looking for uptrend to start IMO



$PALI

[Apprentice]

I'm in! :)
PALI looks exactly like AHPI looked yesterday!
What do you think?
$PALI

[$treet $inatra]

$PALI time to roast some shorties back above $10

[sharky]

PALI Outstanding Shares 7,302,040 as of
05/05/2021



$PALI

[sharky]

PALI nice fishing bid day here IMO. 50dma at 6.66 RSI 36.54



$PALI

[BesaoT35]

Do investors in PALI still have any hope for NSI-189 in Alzheimer’s Disease which is shown to be safe and induces anatomically proven neurogenesis in human hippocampus?

The drug failed in phase 2 for Major Depression several years ago. Perhaps dementia treatment is where the drug belongs.

Being shown to be safe, is there any chance of a “Right to Try” of NSI-189 for patients who are experiencing a cognitive decline and have no real treatments other than the BIIB drug ,recently approved, which has shown a minimal clinical benefit in the phase 3 trials? The BIIB drug showed a 6% rate of worrisome brain inflammation. NSI-189 is already shown to be safe and did help patients clinically in cognitive tests, but did not help with their depression.

NSI-189 was developed when our company was called NeuralStem I think.

Thanks.

[sharky]

GM all, has plenty of room to grow



$PALI

[pitacorp]

small dip on monday, should take off on tuesday........(I hope)

[sharky]

Great to have bids in IMO





$PALI

[Daybull]

No look again at that chart.....it's a no brainer, even if you don't know how to read charts? Bollinger Band says she should be trading at $4.35.

[Baxy]

And Fast Track status!!!

[Baxy]

Definitely worth a lot more than the current company market cap!

[surfgreen]

Massive

[BesaoT35]

How big is the market for the GI surgery drug that PALI is developing?

[traderbbc1]

However, sometimes they surface.

[sharky]

Bottom feeders love blood



$PALI

[traderbbc1]

Cool Picture. Not Chart.

[sharky]

Looking for a bounce IMO.


$PALI

[traderbbc1]

Not sure what is going on here. But this is my worst % loss. Looks like it stock price is on life support. Not sure what is happening with the fundamentals.

[sharky]

PALI In connection with the closing of the Merger and the Pre-Merger Financing, on May 25, 2021, the Company issued to Ecoban (i) a warrant to purchase 18,353 shares of the Company’s common stock (“Common Stock”) at a price of $17.72 per share (the “Ecoban Warrant”) and (ii) 118,833 shares of Common Stock (the “Ecoban Shares”), as payment for a success fee for closing the Merger and Pre-Merger Financing.



The Ecoban Warrant and Ecoban Shares are not registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws. The Company has relied on the exemption from the registration requirements of the Securities Act by virtue of Section 4(a)(2) thereof and Rule 506 of Regulation D thereunder. Ecoban represented to the Company that it is an “accredited investor” as defined in Regulation D of the Securities Act and that the Ecoban Warrant and Ecoban Shares were acquired solely for Ecoban’s own account and for investment purposes and not with a view to the future sale or distribution.



$PALI

[sharky]

PALI RSI at 25.18 oversold





$PALI

[stock1ace1]

Buying today macd pinch.

[traderbbc1]

Death spriral here. Recovery?

[$treet $inatra]

Out today https://patentcenter.uspto.gov/#!/applications/15707943/ifw/docs

[Hattori Hanzo]

Grabbed some in the upper 3s gambling that it’s the bottom, if it isn’t, I’m bailing and looking for borrows

[Disquisition]

My 2.50 bid should fill next week

[$treet $inatra]

Palisade Bio Receives FDA Fast Track Designation https://www.palisadebio.com/news-events/press-releases/news-details/2021/Palisade-Bio-Receives-FDA-Fast-Track-Designation-for-LB1148-for-Reduction-of-Adhesions-Following-Abdominal-and-Pelvic-Surgery/default.aspx

[Disquisition]

UNREAL DUMPING